Literature DB >> 21454688

WITHDRAWN: Restoration of transforming growth factor-beta receptor II expression in colon cancer cells with microsatellite instability increases metastatic potential in vivo.

Xiao-Qiong Liu1, Ashwani Rajput, Liying Geng, Melanie Ongchin, Anathbandhu Chaudhuri, Jing Wang.   

Abstract

Microsatellite instability (MSI), which occurs in 15% of colorectal cancer, has been shown to have a lower incidence of metastasis and better patient survival rates compared with microsatellite stable colorectal cancer. However, a mechanistic understanding of the basis for this difference is very limited. Here, we show that restoration of TGFβ signaling by re-expression of TGFβ receptor II in MSI colon cancer cells increased PI3K/AKT activation, conferred resistance to growth factor deprivation stress-induced apoptosis, and promoted cell motility in vitro. Treatment with a potent PI3K inhibitor (LY294002) blocked the prosurvival and promotility effects of TGFβ, indicating that TGFβ-mediated promotion of cell survival and motility is dependent upon activation of the PI3K/AKT pathway. Analysis of apoptotic effectors that are affected by TGFβ signaling indicated that Bim is an effector of TGFβ-mediated survival. In addition, TGFβ-induced down-regulation of E-cadherin contributed to the prosurvival effect of TGFβ, and restoration of TGFβ signaling in MSI colon cancer cells increased liver metastasis in an orthotopic model in vivo. Taken together, our results demonstrate that restoration of TGFβ signaling promotes cell survival, motility, and metastatic progression in MSI colon cancer cells and indicate that TGFβ receptor II mutations contribute to the favorable outcomes in colon cancer patients with MSI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454688      PMCID: PMC3091217          DOI: 10.1074/jbc.M111.221697

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1.

Authors:  I Shin; A V Bakin; U Rodeck; A Brunet; C L Arteaga
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

2.  Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak.

Authors:  Simon N Willis; Jamie I Fletcher; Thomas Kaufmann; Mark F van Delft; Lin Chen; Peter E Czabotar; Helen Ierino; Erinna F Lee; W Douglas Fairlie; Philippe Bouillet; Andreas Strasser; Ruth M Kluck; Jerry M Adams; David C S Huang
Journal:  Science       Date:  2007-02-09       Impact factor: 47.728

Review 3.  Molecular mechanisms of transforming growth factor-beta signaling.

Authors:  P P Hu; M B Datto; X F Wang
Journal:  Endocr Rev       Date:  1998-06       Impact factor: 19.871

4.  Autocrine TGF-β protects breast cancer cells from apoptosis through reduction of BH3-only protein, Bim.

Authors:  Yukari Hoshino; Yoko Katsuno; Shogo Ehata; Kohei Miyazono
Journal:  J Biochem       Date:  2010-09-29       Impact factor: 3.387

5.  Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties.

Authors:  S P Wu; L Z Sun; J K Willson; L Humphrey; R Kerbel; M G Brattain
Journal:  Cell Growth Differ       Date:  1993-02

Review 6.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

7.  Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells.

Authors:  Shoukang Zhu; Sarah Evans; Bin Yan; Thomas J Povsic; Victor Tapson; Pascal J Goldschmidt-Clermont; Chunming Dong
Journal:  Circulation       Date:  2008-11-03       Impact factor: 29.690

Review 8.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

Authors:  Rik Derynck; Ying E Zhang
Journal:  Nature       Date:  2003-10-09       Impact factor: 49.962

9.  Prohibitin regulates TGF-beta induced apoptosis as a downstream effector of Smad-dependent and -independent signaling.

Authors:  Brian Zhu; Jianjun Zhai; Haining Zhu; Natasha Kyprianou
Journal:  Prostate       Date:  2010-01-01       Impact factor: 4.104

10.  Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim.

Authors:  Rebecca Ley; Kathryn Balmanno; Kathryn Hadfield; Claire Weston; Simon J Cook
Journal:  J Biol Chem       Date:  2003-03-19       Impact factor: 5.157

View more
  9 in total

1.  DSTYK Promotes Metastasis and Chemoresistance via EMT in Colorectal Cancer.

Authors:  Jinyu Zhang; Zachary Miller; Phillip R Musich; Ashlin E Thomas; Zhi Q Yao; Qian Xie; Philip H Howe; Yong Jiang
Journal:  Front Pharmacol       Date:  2020-09-02       Impact factor: 5.810

2.  Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo.

Authors:  M Yu; P Trobridge; Y Wang; S Kanngurn; S M Morris; S Knoblaugh; W M Grady
Journal:  Oncogene       Date:  2013-04-22       Impact factor: 9.867

3.  Masking epistasis between MYC and TGF-β pathways in antiangiogenesis-mediated colon cancer suppression.

Authors:  Michael Dews; Grace S Tan; Stacy Hultine; Pichai Raman; Jaewoo Choi; Elizabeth K Duperret; Jack Lawler; Adam Bass; Andrei Thomas-Tikhonenko
Journal:  J Natl Cancer Inst       Date:  2014-03-13       Impact factor: 13.506

4.  Tumor budding and human chorionic gonadotropin-β expression correlate with unfavorable patient outcome in colorectal carcinoma.

Authors:  Yuji Konishi; Futoshi Kawamata; Hiroshi Nishihara; Shigenori Homma; Yasutaka Kato; Masumi Tsuda; Shinji Kohsaka; Takahiro Einama; Cheng Liu; Tadashi Yoshida; Akihisa Nagatsu; Mishie Tanino; Shinya Tanaka; Hideki Kawamura; Toshiya Kamiyama; Akinobu Taketomi
Journal:  Med Oncol       Date:  2018-06-11       Impact factor: 3.064

5.  Genetic alterations in colorectal cancer.

Authors:  Tannaz Armaghany; Jon D Wilson; Quyen Chu; Glenn Mills
Journal:  Gastrointest Cancer Res       Date:  2012-01

6.  Nucleotide selectivity defect and mutator phenotype conferred by a colon cancer-associated DNA polymerase δ mutation in human cells.

Authors:  T M Mertz; A G Baranovskiy; J Wang; T H Tahirov; P V Shcherbakova
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

7.  Visualization of epithelial-mesenchymal transition in an inflammatory microenvironment-colorectal cancer network.

Authors:  Takeshi Ieda; Hiroshi Tazawa; Hiroki Okabayashi; Shuya Yano; Kunitoshi Shigeyasu; Shinji Kuroda; Toshiaki Ohara; Kazuhiro Noma; Hiroyuki Kishimoto; Masahiko Nishizaki; Shunsuke Kagawa; Yasuhiro Shirakawa; Takashi Saitou; Takeshi Imamura; Toshiyoshi Fujiwara
Journal:  Sci Rep       Date:  2019-11-08       Impact factor: 4.379

Review 8.  TGF-β - an excellent servant but a bad master.

Authors:  Lenka Kubiczkova; Lenka Sedlarikova; Roman Hajek; Sabina Sevcikova
Journal:  J Transl Med       Date:  2012-09-03       Impact factor: 5.531

9.  MicroRNA-192 suppresses liver metastasis of colon cancer.

Authors:  L Geng; A Chaudhuri; G Talmon; J L Wisecarver; C Are; M Brattain; J Wang
Journal:  Oncogene       Date:  2013-11-11       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.